PW Nova Financial Services’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$272K Sell
1,428
-3
-0.2% -$516 0.06% 176
2026
Q1
$242K Buy
1,431
+206
+17% +$35.2K 0.06% 174
2025
Q4
$207K Buy
+1,225
New +$199K 0.08% 106

Other funds holding IBB

PW Nova Financial Services's IBB Position: Q2 2026 in Review

PW Nova Financial Services reduced its iShares Biotechnology ETF (IBB) stake by 0.21% in Q2 2026, selling an estimated $516 and leaving 1,428 shares worth $272K. The position accounts for 0.06% of the portfolio, ranked #176.

PW Nova Financial Services first reported a position in IBB in Q4 2025 and has held it in 3 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • PW Nova Financial Services held 1,428 shares of iShares Biotechnology ETF worth $272K as of Q2 2026.
  • PW Nova Financial Services sold 3 iShares Biotechnology ETF shares in Q2 2026, an estimated $516.
  • iShares Biotechnology ETF made up 0.06% of PW Nova Financial Services's portfolio in Q2 2026, its #176 holding.
  • PW Nova Financial Services first reported a position in iShares Biotechnology ETF in Q4 2025 and has held it in 3 quarters since.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on PW Nova Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.